Also trades as: ALVO (NASDAQ) · $vol 2M
ALVOW NASDAQ
Alvotech
1W: -14.1%
1M: -54.6%
3M: -54.6%
YTD: -80.8%
1Y: -91.2%
3Y: -73.7%
$0.15
+0.00 (+0.00%)
Weekly Expected Move ±114.8%
$-0
$-0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$874.3M
52W Range0.15-1.52
Volume1,098
Avg Volume3,626
Beta0.19
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOLisa Graver
Employees1,279
SectorHealthcare
IndustryBiotechnology
IPO Date2022-06-16
Websitealvotech.com
9, Rue de Bitbourg
Luxembourg, LU L-1273
LU
Luxembourg, LU L-1273
LU
354 422 4500
About Alvotech
Alvotech Holdings SA is an Icelandic enterprise that, operating via its subsidiary companies, undertakes the development and fabrication of biosimilar pharmaceuticals destined for international consumption.
Latest News
Alvotech (ALVO) Stock May Be Undervalued Following Its $125 Million Offering
Glass House Brands (GLAS) Stock Trends and Sentiment 2026 $GLAS - MarketBeat
Alvotech’s US$240 Million Capital Boost Might Change The Case For Investing In Alvotech (ALVO)
Alvotech Warrant (ALVOW) Holds Steady at $0.23 as Buyers and Sellers Reach Equilibrium - Change of Character - dars.gov.et
Alvotech further strengthens liquidity by securing term loan facility of $75 million
Recent Insider Trades
No insider trades found